#
Communiqués de presse

Restez informé avec nos dernières mises à jour et annonces dans le domaine de la santé

Communiqués de presse

Restez informé avec nos dernières mises à jour et annonces dans le domaine de la santé

Asset Publisher

Rexall Launches First Pharmacist Care Walk-In Clinic in Barrie (en anglais seulement)

Local Rexall® pharmacists can now assess and provide required care for common illnesses, addressing immediate healthcare needs and promoting preventive care. 


BARRIE, ON, April 19, 2024 /CNW/ - Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for minor illnesses, as well as services including chronic disease management, vaccinations, men's and women's health, and point-of-care testing, among others.

Rexall's Pharmacist Care Walk-In Clinic is dedicated to enhancing accessible healthcare by increasing the value pharmacists provide to patients, especially when it comes to preventative healthcare and chronic condition management.  We are taking a collaborative approach to work with primary care physicians throughout the Barrie community. Additionally, we offer virtual physician care services when needed, further improving access to comprehensive care for our patients.


"We are pleased to announce the opening of our Pharmacist Care Walk-In Clinic, which will enhance healthcare access in the Barrie community by empowering local pharmacists to assess and provide necessary care for immediate health concerns and improving long-term health outcomes," says Qaiser Hassan, pharmacy manager for the Barrie Rexall Pharmacist Care Walk-In Clinic. "We look forward to empowering individuals in the Barrie community to actively manage a healthy and happy lifestyle. This initiative brings us closer to strengthening the bond between healthcare providers and patients, aligning with Rexall's commitment to caring for Canadians' health, one person at a time."

Services that will be offered to patients at the Pharmacist Care Walk-In Clinic include: 

•    Minor illnesses (mild acne, UTI, pink eye, eczema, cold sores, seasonal allergies, etc.)  
•    Chronic disease management (diabetes, hypertension, etc.)  
•    Women's and men's health
•    Travel health and vaccinations
•    Point of care testing (Lipids, A1C, COVID, etc.)  
•    Immunization and injections  
•    Smoking cessation  
•    Prescription refills and renewals
•    On-site physician virtual care  

The launch event on Friday, April 19th, 2024, will feature a ribbon-cutting ceremony, guided tours of the clinic's state-of-the-art facilities, and a chance to meet the passionate healthcare professionals who will be serving the community.  
For more information, please visit rexall.ca/clinic-duckworth


Rexall Barrie Pharmacy Care Walk-In Clinic Team. Photo by Stephan Potopnyk (CNW Group/Rexall Pharmacy Group ULC.)

Rexall Barrie Pharmacy Care Walk-In Clinic Team. Photo by Stephan Potopnyk (CNW Group/Rexall Pharmacy Group ULC.)

Rexall celebrates their first Ontario pharmacy walk-in clinic opening in Barrie, Ontario. Photo by Stephan Potopnyk (CNW Group/Rexall Pharmacy Group ULC.)

Rexall celebrates their first Ontario pharmacy walk-in clinic opening in Barrie, Ontario. Photo by Stephan Potopnyk (CNW Group/Rexall Pharmacy Group ULC.)

About Rexall 
With a dynamic history of innovation and growth dating back over a century, Rexall is a leading pharmacy retailer in Canada, dedicated to caring for Canada's health, one person at a time. Operating approximately 400 pharmacies across Canada, Rexall's 8,000 employees provide compassionate care to patients, becoming their trusted health partners along their wellness journey.   
Rexall is part of the Rexall Pharmacy Group ULC and a proud member of the global McKesson Canada Corporation family, a diversified healthcare company with deep roots in supporting patients across Canada.  
For more information, visit rexall.ca. Follow us on Twitter: @RexallDrugStore, on Instagram at @RexallDrugStoreOfficial, and @RexallCareNetwork and on Facebook at @RexallDrugStore
SOURCE Rexall Pharmacy Group ULC.
 
For further information: Media Contact, media@rexall.ca

Livres blancs
image
Médicaments pour les maladies rares au Canada: Considérations relatives pour un accès équitables

Assurer un accès complet, opportun et équitable aux médicaments pour les maladies rares est une priorité de la politique publique pour le gouvernement du Canada. La décision du gouvernement d’allouer 500 millions de dollars annuellement à une stratégie nationale relative aux médicaments pour les maladies rares représente un pilier de son travail émergeant sur le régime d’assurance médicaments national. McKesson Canada est fière de contribuer à la conversation sur la politique publique concernant cette stratégie nationale, en s’appuyant sur son expérience avec les programmes de soutien aux patients, la distribution pharmaceutique et les services de pharmacie.

image
The $100 Solution: A PostPandemic Path Forward for National Pharmacare in Canada

The Government of Canada would like to develop a solution to ensure universal drug coverage for Canadians. This solution would mean all Canadians would have access to a comprehensive, affordable drug insurance plan regardless of their province of residence or financial situation. Where the coverage comes from is an important consideration, but what ultimately matters is that all Canadians can acquire the medicine they need regardless of their particular financial, geographic or health circumstances. 

image
De pandémie à endémie: Enseignements de la COVID-19 pour améliorer les campagnes de vaccination au Canada

Peu après le début de la pandémie de COVID-19 au Canada au printemps 2020, il est devenu évident que le retour à la « normale » ne se produirait pas avant qu'une écrasante majorité de Canadiens aient été vaccinés. À l'époque, le vaccin contre la COVID-19 n'existait que dans les plans des scientifiques biomédicaux. En effet, la plupart des observateurs ne prévoyaient pas l'arrivée d'un vaccin commercialisé en masse avant au moins 18 mois. Au-delà du simple développement du vaccin, le secteur pharmaceutique a dû relever le défi sans précédent de la fabrication, du transport, du stockage et de l'administration de milliards de doses.